Bioera Research &Development Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-01-2025
- Paid Up Capital ₹ 0.10 M
as on 07-01-2025
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -7.58%
(FY 2020)
- Profit -5.55%
(FY 2020)
- Ebitda -22.47%
(FY 2020)
- Net Worth 38.37%
(FY 2020)
- Total Assets 93.70%
(FY 2020)
About Bioera Research &Development
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Siddharth Salunke and Asha Salunke serve as directors at the Company.
- CIN/LLPIN
U73100PN2012PTC143064
- Company No.
143064
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2012
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bioera Research &Development?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Salunke  | Director | 23-Apr-2012 | Current |
| Asha Salunke | Director | 23-Apr-2012 | Current |
Financial Performance of Bioera Research &Development.
Bioera Research &Development Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.58% decrease. The company also saw a slight decrease in profitability, with a 5.55% decrease in profit. The company's net worth Soared by an impressive increase of 38.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioera Research &Development?
In 2019, Bioera Research &Development had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bioera Life Sciences Private LimitedActive 15 years 6 monthsSiddharth Salunke and Asha Salunke are mutual person
Bioera Nutriments Private LimitedActive 11 months 18 daysSiddharth Salunke and Asha Salunke are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bioera Research &Development?
Unlock and access historical data on people associated with Bioera Research &Development, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioera Research &Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioera Research &Development's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.